Patent · US Active

Hilbert-cnn: ai-driven convolutional neural networks with conversion data of genome for biomarker discovery

US11804285B2 · kind B2 · utility

0Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 21, 2018
Grant dateOct 31, 2023
Priority date
Expiry dateJun 23, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B40/20
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

A method of detecting biomarkers using an artificial intelligence (AI) deep learning model for conversion data of nucleotide sequences and mutations of population genomes, the method including: collecting nucleotide sequences and mutations of population genomes; generating conversion data by reflecting mutations of diploid genomes in the collected nucleotide sequences; performing an artificial intelligence (AI) deep learning model with the generated conversion data; generating a fully connected network (FCN) by connecting the results obtained by the machine learning; and extracting biomarkers by the learned model.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.